Praxis Precision Medicines, Inc. PRAX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -45.8%+25.2pp | -71%+98.2pp | -169.1%-38.2pp | -130.9%-68.9pp | |
| Return on invested capital | -86.8%— | —— | —— | -323.3%— | |
| Efficiency | |||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×— | 0×— | |
| Liquidity | |||||
| Current ratio | 10.2×-0.5× | 10.8×+5.4× | 5.4×+2.2× | 3.2×-4.3× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | |||||
| Book value per share | $39.02+56.9% | $24.88+135% | $10.57-57.3% | $24.77+319% | |
| Valuation | |||||
| Market capitalization | $7.37B+414% | $1.43B+651% | $190.94M+70.3% | $112.14M-87.3% | |
| Price / book | 8.4×+5.2× | 3.2×+0.5× | 2.7×+1.3× | 1.5×-2.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Praxis Precision Medicines, Inc.'s ratios come from?
- Every ratio is computed from Praxis Precision Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.